Access Bio Signs Supply Contract Worth 13.3 Billion KRW
[Asia Economy Reporter Oh Ju-yeon] Access Bio announced on the 3rd that it has signed a supply contract worth 13.3 billion KRW with the US company Intrivo Diagnostics for the novel coronavirus infection (COVID-19). This amount corresponds to 30.85% of its recent sales revenue.
Hot Picks Today
Cerebras Soars 70% on IPO Debut: Is Nvidia's Reign Ending as a New AI Semiconductor Power Emerges?
- [Breaking] Samsung Electronics Executives: "We Will Participate Unconditionally... We Urge the Union to Join the Talks"
- "Gave in to the Momentary Temptation": Japanese Police Official Dismissed After Stealing 100 Million Won Next to Body
- "Mom, Isn't It Comfortable Living With Me?"... 'Unexpected Result' Shows Increased Drinking Out of Frustration
- "After Vowing to Become No. 1 Globally, Sudden Policy Brake Puts Companies’ Massive Investments at Risk"
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
